Lipid Nanoparticles for Gene Therapy Market Research 2024: Gene Therapy Sales are Projected to Exceed $10bn by 2027 - LNPs have Gained Popularity as Carriers for Gene Therapies
September 18, 2024 09:05 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Gene therapy - Lipid nanoparticles" report has been added to ResearchAndMarkets.com's offering.This report discusses the developing trend and...
Polymeric Nanoparticles Strategic Business Report 2023-2024 & 2030 - Growing Interest in Non-Toxic and Biodegradable Nanoparticles Bodes Well for Market Growth
September 17, 2024 07:44 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Polymeric Nanoparticles - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymeric...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candi-date Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against
Polymer Nanocomposites Strategic Business Report 2024-2030: Revolutionizing Material Science with Nano-Innovations
September 06, 2024 07:27 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Polymer Nanocomposites - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymer...
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
Metal and Metal Oxide Nanoparticle Market Report 2024-2030, Featuring American Elements, Nanoshell, Meliorum Technologies, EPRUI Nanoparticles & Microspheres, NanoScale and Reinste Nanoventures
August 13, 2024 10:00 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Metal and Metal Oxide Nanoparticle Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Nanoparticles Titanium Dioxide Market Research - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F
July 09, 2024 10:58 ET
|
Research and Markets
Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "Nanoparticles Titanium Dioxide Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F" report has been added to ...
Magnesium Oxide Nanoparticles Market Research 2024 - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F
July 09, 2024 10:56 ET
|
Research and Markets
Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "Magnesium Oxide Nanoparticles Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F" report has been added to ...